SCHEMBL1505829

SCHEMBL1505829

Cc1ccc(-c2c3ccccc3c(Br)c3ccccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.49
GSK3B P49841 1/20 0.39
ADK P55263 1/20 0.39
ALDH1A1 P00352 6/20 0.39
PTGS2 P35354 2/20 0.38
PDE9A O76083 1/20 0.38
PDE1C Q14123 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 2/20 0.38
GAA P10253 1/20 0.38
KDM4E B2RXH2 2/20 0.37
ADORA2A P29274 1/20 0.37
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889060 0.89 ACHE (0.43) ACHEGSK3BADKALDH1A1PTGS2
SCHEMBL3284458 0.89 ACHE (0.41) ACHEGSK3BADKALDH1A1PTGS2
SCHEMBL3000291 0.89 KDM4E (0.42) ACHEALDH1A1MAPK1KDM4EMAPT
SCHEMBL30742831 0.89 ACHE (0.57) ACHEGSK3BADKALDH1A1PTGS2
SCHEMBL3477351 0.89 ACHE (0.57) ACHEGSK3BADKALDH1A1PTGS2
SCHEMBL12795063 0.87 ALDH1A1 (0.56) ACHEGSK3BADKALDH1A1PTGS2
SCHEMBL9612496 0.85 BRD9 (0.40) ACHEALDH1A1MEN1KMT2AMAPK1
SCHEMBL30924193 0.84 ACHE (0.58) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL21224502 0.84 ACHE (0.58) ACHEGSK3BADKALDH1A1SMN1; SMN2
SCHEMBL12560663 0.84 MAPK1 (0.48) ACHEALDH1A1MAPK1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104086596-B Phosphorescent iridium complex, and preparation method and application thereof 南京邮电大学 2017-01-25 CN claimed
CN-104086596-A Phosphorescent iridium complex, and preparation method and application thereof UNIV NANJING POSTS & TELECOMM 2014-10-08 CN claimed
US-11515481-B2 Composition for forming organic film, display device using the composition, and method of manufacturing the display device SAMSUNG DISPLAY CO., LTD. (KR) 2022-11-29 US disclosed
US-20190019958-A1 COMPOSITION FOR FORMING ORGANIC FILM, DISPLAY DEVICE USING THE COMPOSITION, AND METHOD OF MANUFACTURING THE DISPLAY DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-01-17 US disclosed
CN-104086596-B Phosphorescent iridium complex, and preparation method and application thereof 南京邮电大学 2017-01-25 CN disclosed
US-8986852-B2 Benzanthracene derivatives for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-24 US disclosed
US-8986852-B2 Benzanthracene derivatives for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-24 US disclosed
CN-104086596-A Phosphorescent iridium complex, and preparation method and application thereof UNIV NANJING POSTS & TELECOMM 2014-10-08 CN disclosed
US-8283855-B2 Method for synthesis of anthracene derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-09 US disclosed
US-8283855-B2 Method for synthesis of anthracene derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-09 US disclosed
CN-101153036-B Organic light-emitting compound and organic light-emitting element comprising the same SAMSUNG MOBILE DISPLAY CO LTD 2012-10-03 CN disclosed
US-20100187505-A1 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES IDEMITSU KOSAN CO., LTD. (JP) 2010-07-29 US disclosed
US-20100187505-A1 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES IDEMITSU KOSAN CO., LTD. (JP) 2010-07-29 US disclosed
WO-2008145239-A2 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2008-12-04 WO disclosed
CN-101153036-A Organic light-emitting compound and organic light-emitting element comprising the same SAMSUNG SDI CO LTD (KR) 2008-04-02 CN disclosed
US-20070072002-A1 Organic light-emitting compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-03-29 US disclosed
US-20070072002-A1 Organic light-emitting compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-03-29 US disclosed
US-20070072002-A1 Organic light-emitting compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-03-29 US disclosed
US-7166240-B2 Hydrocarbon compounds, materials for organic electroluminescent elements and organic electroluminescent elements MITSUI CHEMICALS, INC. (JP) 2007-01-23 US disclosed
US-20050074631-A1 Hydrocarbon compounds, materials for organic electroluminescent elements and organic electroluminescent elements MITSUI CHEMICALS, INC. (JP) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100187505-A1 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES KCNT1, KCNC1, TMEM109 ACHE 1228/4885GSK3B 4118/4885ADK 3946/4885
US-20190019958-A1 COMPOSITION FOR FORMING ORGANIC FILM, DISPLAY DEVICE USING THE COMPOSITION, AND METHOD OF MANUFACTURING THE DISPLAY DEVICE OCIAD1, OCIAD2, OR10J3 ACHE 1379/4885GSK3B 2227/4885ADK 2388/4885
US-11515481-B2 Composition for forming organic film, display device using the composition, and method of manufacturing the display device OR10J3, ILK, RER1 ACHE 1775/4885GSK3B 2490/4885ADK 1691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.